Information Journal Paper
APA:
Copy. (2018). Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-tat-based vaccine candidate to elicit cellular immunity in BALB/c mice. BIOTECHNOLOGY LETTERS, 40(3), 527-533. SID. https://sid.ir/paper/755166/en
Vancouver:
Copy. Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-tat-based vaccine candidate to elicit cellular immunity in BALB/c mice. BIOTECHNOLOGY LETTERS[Internet]. 2018;40(3):527-533. Available from: https://sid.ir/paper/755166/en
IEEE:
Copy, “Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-tat-based vaccine candidate to elicit cellular immunity in BALB/c mice,” BIOTECHNOLOGY LETTERS, vol. 40, no. 3, pp. 527–533, 2018, [Online]. Available: https://sid.ir/paper/755166/en